Precision medicine is revolutionizing healthcare, and these genomic stocks are leading the way. Therefore, as this sector ...

ZeroAvia has agreed the certification basis with the US Federal Aviation Administration for its 600kW electric propulsion ...

Becton Dickinson and Company BDX, popularly known as BD, is scheduled to report first-quarter fiscal 2025 results on Feb. 6, ...

Charles River Laboratories International, Inc. CRL is scheduled to report fourth-quarter 2024 results on Feb.19, before ...

Vertex Pharmaceuticals (VRTX) stock has performed strongly since the turn of the year, gaining 14.6% and vastly outperforming ...

Investment analysts at Leerink Partnrs lifted their FY2026 EPS estimates for REGENXBIO in a research note issued on Wednesday, January 29th. Leerink Partnrs analyst M. Foroohar now expects that the ...

Cantor Fitzgerald upgraded shares of Beam Therapeutics (NASDAQ:BEAM – Free Report) from a neutral rating to an overweight rating in a research note published on Wednesday morning, Marketbeat reports.

A sugar produced by soil bacteria may be able to stop the loss of skin pigment caused by vitiligo.  | A sugar produced by ...

Alphamin continues to thrill and disappoint, appreciating a pedestrian 20% despite excellent results. Click here to read more ...

Ad hoc announcement pursuant to Art. 53 LR Full year Net sales grew +12% (cc1, +11% USD) with core operating income1 up +22% (cc, +19% USD) Sales growth driven by continued strong performance ...

Deliver returns: Continuing to embed operational excellence and deliver improved financials. Novartis remains disciplined and shareholder-focused in our approach to capital allocation, with ...

Don't let your cell plan drain your wallet—here's how to spot when it's time for a better deal. iOS 18.3 is out now. It delivers key features and an important default setting change. Starbucks' new ...